Scientists funded by the National Eye Institute (NEI) report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.
Related posts:
- Medicare Card, Gene therapy staves off blindness from retinitis pigmentosa in canine model Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for […]...
- Medicare Card, NIH-funded study points way forward for retinal disease gene therapy Medicare Card, NIH-funded study points way forward for retinal disease gene therapy...
- Medicare Card, NIH study provides clarity on supplements for protection against blinding eye disease Medicare Card, NIH study provides clarity on supplements for protection against blinding eye disease...
- Medicare Card, Researchers find a gap in the brain’s firewall against Parkinson’s disease Medicare Card, Researchers find a gap in the brain’s firewall against Parkinson’s disease...
- Medicare Card, Gene therapy shows promise for treating Niemann-Pick disease type C1 Medicare Card, Gene therapy shows promise for treating Niemann-Pick disease type C1...
- Medicare Card, Batten disease may benefit from gene therapy Medicare Card, Batten disease may benefit from gene therapy...
- NIH-Supported ACCORD Eye Study Finds Two Therapies Slow Diabetic Eye Disease Progression In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans....
- Medicare Card, Suppressing Protein May Stem Alzheimer’s Disease Process Medicare Card, Suppressing Protein May Stem Alzheimer’s Disease Process...
- Medicare Card, NIH researchers find potential target for reducing obesity-related inflammation Medicare Card, NIH researchers find potential target for reducing obesity-related inflammation...
- Medicare Card, Suppressing protein may stem Alzheimer’s disease process Medicare Card, Suppressing protein may stem Alzheimer's disease process...
- Medicare Card, NIH researchers identify candidate drug to treat Batten disease Medicare Card, NIH researchers identify candidate drug to treat Batten disease...
- Medicare Card, NIH-funded researchers create next-generation Alzheimer’s disease model Medicare Card, NIH-funded researchers create next-generation Alzheimer's disease model...
- NIH Encourages Americans to Make Vision a Priority NIH Encourages Americans to Make Vision a Priority ...
- Medicare Help, Immune Cell’s Role, Lupus Nephritis Demonstrated, Paves Way for Safety Testing, of Potential New Use for Asthma Drug National Institutes of Health scientists have discovered that the activation of immune cells called basophils causes kidney damage in a mouse model of lupus nephritis. These findings and the team’s associated research in humans may lead to new treatments for this serious disease, a severe form of systemic lupus erythematosus (SLE) that affects the kidneys […]...
- Medicare Card, Researchers examine how Parkinson’s disease alters brain activity over time Medicare Card, Researchers examine how Parkinson’s disease alters brain activity over time...